These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y; Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [TBL] [Abstract][Full Text] [Related]
4. Manifestations of Mucormycosis and Its Complications in COVID-19 Patients: A Case Series Study. Kordjazi M; Bazgir N; Eftekharian K; Farajpour M; Dilmaghani NA Ear Nose Throat J; 2024 Jun; 103(1_suppl):145S-152S. PubMed ID: 36583239 [TBL] [Abstract][Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848 [TBL] [Abstract][Full Text] [Related]
6. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study. Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399 [TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center. Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975 [No Abstract] [Full Text] [Related]
8. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140 [TBL] [Abstract][Full Text] [Related]
9. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988 [TBL] [Abstract][Full Text] [Related]
10. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124 [TBL] [Abstract][Full Text] [Related]
11. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome. Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868 [TBL] [Abstract][Full Text] [Related]
12. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287 [TBL] [Abstract][Full Text] [Related]
13. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study. Manesh A; Devasagayam E; Bhanuprasad K; Varghese L; Kurien R; Cherian LM; Dayanand D; George MM; Kumar SS; Karthik R; Vanjare H; Peter J; Michael JS; Thomas M; Mathew BS; Samuel P; Peerawaranun P; Mukaka M; Rupa V; Varghese GM Clin Microbiol Infect; 2023 Oct; 29(10):1298-1305. PubMed ID: 37348653 [TBL] [Abstract][Full Text] [Related]
14. Rise of the phoenix: Mucormycosis in COVID-19 times. Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742 [TBL] [Abstract][Full Text] [Related]
15. [Rhino-orbito-cerebral mucormycosis: two case reports in the light of the literature]. Kara M; Erdoğan H; Toroslu T; Akçalı A; Tatman Okun M; Reşorlu M; Dereköy FS Kulak Burun Bogaz Ihtis Derg; 2015; 25(5):295-301. PubMed ID: 26476519 [TBL] [Abstract][Full Text] [Related]
16. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review. Nair AG; Dave TV Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026 [TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904 [TBL] [Abstract][Full Text] [Related]
18. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B. Guimarães JA; Moura FC Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552 [TBL] [Abstract][Full Text] [Related]
19. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712 [TBL] [Abstract][Full Text] [Related]
20. Spectrum of orbital fat necrosis in rhino-orbital-cerebral mucormycosis in post-COVID-19 patients. Agrawal A; Diwaker P; Dixit S; Rohatgi J; Arora VK Indian J Ophthalmol; 2024 Oct; 72(10):1478-1482. PubMed ID: 39331438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]